newsfilter
← Latest News
ACCESS Newswire·

Cleveland BioLabs, Inc. Announces Closing of $14 Million Registered Direct Offering of Common Stock

Cleveland BioLabs, Inc. (NASDAQ:CBLI), today announced that it has closed its previously announced registered direct offering for the issuance and sale of 2,000,000 shares of its common stock at a purchase price of $7.00 per share.